» Articles » PMID: 17229557

Cell Cycle Molecules Define a Pathway Required for Neuron Death in Development and Disease

Overview
Specialties Biochemistry
Biophysics
Date 2007 Jan 19
PMID 17229557
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

We review here evidence defining a molecular pathway that includes cell cycle-related molecules and that appears to play a required role in neuron death during normal development as well as in disease and trauma. The pathway starts with inappropriate activation of cyclin dependent kinase 4 (Cdk4) in neurons which leads to hyper-phosphorylation of the pRb family member p130. This in turn results in dissociation of p130 and its associated chromatin modifiers Suv39H1 and HDAC1 from the transcription factor E2F4. Dissociation of this complex results in de-repression of genes with E2F binding sites including those encoding the transcription factors B- and C-Myb. Once elevated in neurons, B- and C-Myb proteins bind to the promoter for the pro-apoptotic BH3-only protein Bim and promote its induction. Bim then interacts with the core cellular apoptotic machinery, leading to caspase activation and apoptotic death. This pathway is supported by a variety of observations and experimental findings that implicate it as a required element for neuron loss in development and in many nervous system traumas and disorders. The components of this pathway appear to represent potential therapeutic targets for prevention of disease-associated neuron death.

Citing Articles

Cyclin-dependent kinases: Masters of the eukaryotic universe.

Pluta A, Studniarek C, Murphy S, Norbury C Wiley Interdiscip Rev RNA. 2023; :e1816.

PMID: 37718413 PMC: 10909489. DOI: 10.1002/wrna.1816.


Emerging nano-scale delivery systems for the treatment of osteoporosis.

Dayanandan A, Cho W, Kang H, Bello A, Kim B, Arai Y Biomater Res. 2023; 27(1):68.

PMID: 37443121 PMC: 10347748. DOI: 10.1186/s40824-023-00413-7.


CDK2 regulates aminoglycoside-induced hair cell death through modulating c-Jun activity: Inhibiting CDK2 to preserve hearing.

Tao L, Segil N Front Mol Neurosci. 2022; 15:1013383.

PMID: 36311033 PMC: 9606710. DOI: 10.3389/fnmol.2022.1013383.


Relationship between Neuroglial Apoptosis and Neuroinflammation in the Epileptic Focus of the Brain and in the Blood of Patients with Drug-Resistant Epilepsy.

Sokolova T, Zabrodskaya Y, Litovchenko A, Paramonova N, Kasumov V, Kravtsova S Int J Mol Sci. 2022; 23(20).

PMID: 36293411 PMC: 9603914. DOI: 10.3390/ijms232012561.


E2F4DN Transgenic Mice: A Tool for the Evaluation of E2F4 as a Therapeutic Target in Neuropathology and Brain Aging.

Ramon-Landreau M, Sanchez-Puelles C, Lopez-Sanchez N, Lozano-Urena A, Llabres-Mas A, Frade J Int J Mol Sci. 2022; 23(20).

PMID: 36292945 PMC: 9603043. DOI: 10.3390/ijms232012093.


References
1.
Lefevre K, Clarke P, Danthe E, Castagne V . Involvement of cyclin-dependent kinases in axotomy-induced retinal ganglion cell death. J Comp Neurol. 2002; 447(1):72-81. DOI: 10.1002/cne.10215. View

2.
Liu D, Nath N, Chellappan S, Greene L . Regulation of neuron survival and death by p130 and associated chromatin modifiers. Genes Dev. 2005; 19(6):719-32. PMC: 1065725. DOI: 10.1101/gad.1296405. View

3.
Sala A . B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer. Eur J Cancer. 2005; 41(16):2479-84. DOI: 10.1016/j.ejca.2005.08.004. View

4.
Jordan-Sciutto K, Dorsey R, Chalovich E, Hammond R, Achim C . Expression patterns of retinoblastoma protein in Parkinson disease. J Neuropathol Exp Neurol. 2003; 62(1):68-74. DOI: 10.1093/jnen/62.1.68. View

5.
Jordan-Sciutto K, Malaiyandi L, Bowser R . Altered distribution of cell cycle transcriptional regulators during Alzheimer disease. J Neuropathol Exp Neurol. 2002; 61(4):358-67. PMC: 3683585. DOI: 10.1093/jnen/61.4.358. View